GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » EV-to-Revenue
中文

Verici Dx (Verici Dx) EV-to-Revenue : 1,017.58 (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Verici Dx's enterprise value is $19.33 Mil. Verici Dx's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.02 Mil. Therefore, Verici Dx's EV-to-Revenue for today is 1,017.58.

The historical rank and industry rank for Verici Dx's EV-to-Revenue or its related term are showing as below:

VRCDF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 1045.47

VRCDF's EV-to-Revenue is ranked worse than
99.12% of 227 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.02 vs VRCDF: 1045.47

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Verici Dx's stock price is $0.12. Verici Dx's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Therefore, Verici Dx's PS Ratio for today is .


Verici Dx EV-to-Revenue Historical Data

The historical data trend for Verici Dx's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx EV-to-Revenue Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22
EV-to-Revenue
- - -

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-Revenue - - - - -

Competitive Comparison of Verici Dx's EV-to-Revenue

For the Diagnostics & Research subindustry, Verici Dx's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Verici Dx's EV-to-Revenue falls into.



Verici Dx EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Verici Dx's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19.334/0.019
=1,017.58

Verici Dx's current Enterprise Value is $19.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Verici Dx's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verici Dx  (OTCPK:VRCDF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Verici Dx's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.12/0
=

Verici Dx's share price for today is $0.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verici Dx EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Verici Dx's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx (Verici Dx) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (Verici Dx) Headlines

No Headlines